<div id="readability-page-1"><p>Renaissance Technologies LLC cut its stake in  CME Group Inc. (NASDAQ:CME - Free Report) by 21.9% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor  owned 1,095,589 shares of the financial services provider's stock after selling 307,500 shares during the quarter. Renaissance Technologies LLC owned about 0.30% of CME Group worth $254,429,000 at the end of the most recent quarter.</p><ul><li>4 Stocks Planning to Return Capital With Hefty Buyback Programs</li></ul><p>Several other institutional investors and hedge funds have also recently modified their holdings of the stock. SJS Investment Consulting Inc. lifted its holdings in  CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider's stock worth $26,000 after buying an additional 97 shares during the period.  Dunhill Financial LLC boosted its position in shares of  CME Group by 188.4% during the third quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider's stock valued at $27,000 after purchasing an additional 81 shares in the last quarter.  New Age Alpha Advisors LLC grew its stake in  CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock worth $30,000 after purchasing an additional 43 shares during the period.  Financial Life Planners purchased a new position in  CME Group during the fourth quarter valued at $32,000.  Finally, Knuff &amp; Co LLC bought a new stake in shares of  CME Group during the 4th quarter valued at $33,000. 87.75% of the stock is owned by hedge funds and other institutional investors. </p><h2>CME Group Trading Down 0.8 %</h2><p>CME Group stock opened at $252.37 on Tuesday. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $273.42. The firm has a market capitalization of $90.94 billion, a price-to-earnings ratio of 26.10, a P/E/G ratio of 6.76 and a beta of 0.43. The firm has a 50 day moving average of $252.91 and a 200 day moving average of $237.72. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. </p><ul><li>Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?</li></ul><p>CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%.  As a group, research analysts predict that  CME Group Inc. will post 10.49 earnings per share for the current year. </p><h2>CME Group Increases Dividend</h2><p>The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.98%. This is an increase from CME Group's previous quarterly dividend of $1.15. The ex-dividend date  was Friday, March 7th. CME Group's dividend payout ratio  is presently 51.71%. </p><h2>Analyst Upgrades and Downgrades</h2><ul><li>Kinder Morgan Stock Bid Up In An Oil Breakout</li></ul><p>A number of research analysts recently issued reports on CME shares. Royal Bank of Canada  reissued a &#34;sector perform&#34; rating and set a $269.00 price target on shares of CME Group in a research report on Thursday, April 3rd. Bank of America raised their price target on CME Group from $200.00 to $219.00 and gave the company an &#34;underperform&#34; rating in a report on Wednesday, April 2nd. Raymond James upgraded shares of CME Group from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating and set a $287.00 price target on the stock in a research note on Monday, March 10th. Piper Sandler lifted their target price on shares of CME Group from $250.00 to $258.00 and gave the stock an &#34;overweight&#34; rating in a report on Tuesday, January 7th. Finally, Oppenheimer raised their price target on shares of CME Group from $258.00 to $269.00 and gave the company an &#34;outperform&#34; rating in a research report on Thursday, February 13th. Four equities research analysts have rated the stock with a sell rating, eight have issued  a hold rating, three have given a buy rating and one  has given a strong buy rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of &#34;Hold&#34; and an average price target of $242.60.</p><p><b>View Our Latest Research Report on CME Group</b></p><h2>Insider Buying and Selling at CME Group</h2><p>In other news, Director Howard J. Siegel sold 10,000 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were sold at an average price of $260.00, for a total value of $2,600,000.00. Following the sale, the director now directly owns 21,873 shares in the company, valued at $5,686,980. The trade was a 31.37 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the business's stock in a transaction that occurred on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the transaction, the chief operating officer now directly owns 8,036 shares in the company, valued at approximately $2,063,885.88. This represents a 15.73 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 27,076 shares of company stock valued at $6,871,496 in the last three months. 0.30% of the stock is currently owned by corporate insiders. </p><h2>CME Group Company Profile</h2> (Free Report)<p>CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.</p><h2>Read More</h2><ul><li>Five stocks we like better than CME Group</li><li>Stock Analyst Ratings and Canadian Analyst Ratings</li><li>Dow's Nuclear Gamble: A Bold Step in Turbulent Times</li><li>How to Invest in the Best Canadian Stocks </li><li>Options Activity Points to More Volatility for Palantir Stock</li><li>Utilities Stocks Explained – How and Why to Invest in Utilities</li><li>NVIDIA Stock: Oversold, Undervalued — How Low Can It Go?</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q01F?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q01F"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in CME Group Right Now?</h2><p>Before you consider CME Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.</p><p>While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Renaissance Technologies LLC reduced its stake in CME Group Inc. by 21.9% in Q4, selling 307,500 shares, leaving it with 1,095,589 shares valued at approximately $254.4 million. Other institutional investors also adjusted their holdings. CME Group's stock opened at $252.37, with a 12-month range of $190.70 to $273.42. The company recently reported earnings of $2.52 per share, exceeding estimates, and announced a dividend increase to $1.25 per share. Analysts have mixed ratings on the stock, with an average target price of $242.60.</p>

Renaissance Technologies LLC Sells 307,500 Shares of CME Group Inc. (NASDAQ:CME)